// Auto-generated - do not edit
export const substanceName = "5F-PB-22";
export const sources = [{"id":"protestkit","fileName":"PROTESTKIT - 5F-PB-22.json","displayName":"Protest Kit","size":6159},{"id":"tripsit-factsheets","fileName":"TRIPSIT_FACTSHEETS - 5F-PB-22.md","displayName":"TripSit Factsheets","size":606},{"id":"wikipedia","fileName":"WIKIPEDIA - 5F-PB-22.md","displayName":"Wikipedia","size":997}];
export const contents: Record<string, string> = {
  "protestkit": `{
  "url": "https://psychonautwiki.org/wiki/5F-PB-22",
  "experiencesUrl": "https://www.reddit.com/search/?q=5F-PB-22",
  "name": "5F-PB-22",
  "aliases": [],
  "aliasesStr": "",
  "summary": "Synthetic cannabinoid, agonist of the cannabinoid receptors which has a strong sedating aspect. Being a synthetic cannabinoid it has a very fast onset.",
  "reagents": null,
  "classes": {
    "chemical": [
      "Indolecarboxylate"
    ],
    "psychoactive": [
      "Cannabinoid"
    ]
  },
  "toxicity": [
    "exact toxic dosage is unknown"
  ],
  "addictionPotential": "moderately addictive with a high potential for abuse",
  "tolerance": {
    "full": "develops with prolonged and repeated use",
    "half": "3 - 7 days",
    "zero": "1 - 2 weeks"
  },
  "crossTolerances": [
    "cannabinoids"
  ],
  "roas": [
    {
      "name": "Smoked",
      "dosage": [
        {
          "name": "Threshold",
          "value": "1  mg"
        },
        {
          "name": "Light",
          "value": "1 - 3 mg"
        },
        {
          "name": "Common",
          "value": "3 - 5 mg"
        },
        {
          "name": "Strong",
          "value": "5 - 8 mg"
        },
        {
          "name": "Heavy",
          "value": "8 mg +"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "0.0 - 0.0 hours"
        },
        {
          "name": "Peak",
          "value": "0.5 - 0.5 hours"
        },
        {
          "name": "Offset",
          "value": "1.0 - 1.0 hours"
        },
        {
          "name": "Total",
          "value": "1.5 - 1.5 hours"
        },
        {
          "name": "After effects",
          "value": "0.25 - 0.25 hours"
        }
      ]
    },
    {
      "name": "Oral",
      "dosage": [
        {
          "name": "Threshold",
          "value": "1 mg"
        },
        {
          "name": "Light",
          "value": "1 - 3 mg"
        },
        {
          "name": "Common",
          "value": "3 - 5 mg"
        },
        {
          "name": "Strong",
          "value": "5 - 8 mg"
        },
        {
          "name": "Heavy",
          "value": "8 mg +"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "0.5 - 0.5 hours"
        },
        {
          "name": "Peak",
          "value": "1.5 - 1.5 hours"
        },
        {
          "name": "Offset",
          "value": "1.0 - 1.0 hours"
        },
        {
          "name": "Total",
          "value": "2.0 - 3.0 hours"
        },
        {
          "name": "After effects",
          "value": "0.5 - 0.5 hours"
        }
      ]
    }
  ],
  "interactions": [
    {
      "name": "2C-T-x",
      "status": "Caution"
    },
    {
      "name": "2C-x",
      "status": "Caution"
    },
    {
      "name": "5-MeO-xxT",
      "status": "Caution"
    },
    {
      "name": "Alcohol",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Amphetamines",
      "status": "Caution"
    },
    {
      "name": "Benzos",
      "status": "Low Risk & Decrease"
    },
    {
      "name": "Caffeine",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Cocaine",
      "status": "Caution"
    },
    {
      "name": "DMT",
      "status": "Caution"
    },
    {
      "name": "DOx",
      "status": "Caution"
    },
    {
      "name": "DXM",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "GHB/GBL",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Gabapentinoids",
      "status": "Unsafe"
    },
    {
      "name": "Ketamine",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "LSD",
      "status": "Caution"
    },
    {
      "name": "MAOIs",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MDMA",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MMC class",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "MXE",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Mescaline",
      "status": "Caution"
    },
    {
      "name": "Mushrooms",
      "status": "Caution"
    },
    {
      "name": "NBOMes",
      "status": "Caution"
    },
    {
      "name": "Nitrous",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "Opioids",
      "status": "Low Risk & Synergy"
    },
    {
      "name": "PDA5",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "PVP class",
      "status": "Caution"
    },
    {
      "name": "Poppers",
      "status": "Unsafe"
    },
    {
      "name": "SSRIs",
      "status": "Low Risk & No Synergy"
    },
    {
      "name": "Tramadol",
      "status": "Low Risk & Synergy"
    }
  ],
  "effects": "Geometry, Thought connectivity, Dehydration, Spontaneous bodily sensations, Changes in felt gravity, Vasodilation, Mindfulness, Conceptual thinking, Cognitive euphoria, Anxiety, Paranoia, Thought deceleration, Dream suppression, Perception of bodily heaviness, Sedation, Motor control loss, Pain relief, Color enhancement, Increased heart rate, Increased music appreciation, Emotion intensification, Visual acuity suppression, Psychosis, Immersion intensification, Auditory acuity enhancement, Appetite intensification, Analysis depression",
  "categorized_effects": {
    "Physical effects": [
      "Dehydration",
      "Vasodilation",
      "Sedation",
      "Motor control loss",
      "Pain relief",
      "Increased heart rate",
      "Appetite intensification"
    ],
    "Mental effects": [
      "Thought connectivity",
      "Mindfulness",
      "Conceptual thinking",
      "Cognitive euphoria",
      "Anxiety",
      "Paranoia",
      "Thought deceleration",
      "Dream suppression",
      "Increased music appreciation",
      "Emotion intensification",
      "Psychosis",
      "Immersion intensification",
      "Analysis depression"
    ],
    "Sensory effects": [
      "Spontaneous bodily sensations",
      "Changes in felt gravity",
      "Perception of bodily heaviness",
      "Color enhancement",
      "Visual acuity suppression",
      "Auditory acuity enhancement"
    ],
    "Uncategorized effects": [
      "Geometry"
    ]
  }
}`,
  "tripsit-factsheets": `# 5F-PB-22
*Source: TripSit Factsheets (tripsit.me)*

## Summary

Synthetic cannabinoid, agonist of the cannabinoid receptors which has a strong sedating aspect. The drug has a fast onset as common with synthetic cannabinoid.

## Classification
- **Categories:** tentative, research-chemical, habit-forming

## Dosage

### Oral
- **Common:** 3-5mg
- **Light:** 1-3mg
- **Strong:** 5-8mg.
- **Threshold:** 1mg

*Note:  Note: As with all research chemicals, start with a low dose, and work your way up.*

## Duration
- **Onset:** 5-10 minutes
- **Duration:** 60-90 minutes
- **After Effects:** 30-60 minutes
`,
  "wikipedia": `# 5F-PB-22
*Source: https://en.wikipedia.org/wiki/5F-PB-22*

5F-PB-22 (5F-QUPIC or quinolin-8-yl 1-pentyfluoro-1H-indole-3-8-carboxylate) is a designer drug which acts as a cannabinoid agonist. The structure of 5F-PB-22 appears to have been designed with an understanding of structureâ€“activity relationships within the indole class of cannabinoids.

## Pharmacology

5F-PB-22 acts as a full agonist with a binding affinity of 0.468 nM at CB1 and 0.633 nM at CB2 cannabinoid receptors.

## Legal status

As of October 2015 5F-PB-22 is a controlled substance in China.
In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States after several deaths were associated with its use.
In the United Kingdom, 5F-PB-22 is now classified and controlled as a Class B drug, following the November 2016 amendment to the Misuse of Drugs Act 1971. Several other synthetic cannabinoids structurally related to JWH-018, like 5F-PB-22, were also classified in this amendment.
`,
};
